Dr. Antonios Kolios is a physician-scientist specializing in dermatology, venereology, clinical immunology, and allergology. He is the division head of Dermatology and Clinical Immunology at Hospital Uster, Switzerland. He specializes in systemic and cutaneous inflammatory diseases with a focus on psoriasis, hidradenitis suppurativa, lupus, vitiligo, and pityriasis rubra pilaris, among others. Dr. Kolios’s research group focuses on translational immunodermatology with the restoration of immune tolerance. His group’s work pursues three main directions: molecular profiling with disease characterization, including metabolomics, restoration of immune tolerance by novel treatment applications, and finally, drug discovery and design of novel therapeutics. Between 2020 and 2021, Dr. Kolios worked at the Beth Israel Deaconess Medical Center (BIDMC) / Harvard Medical School in Boston, Massachusetts, in the Department of Rheumatology and Clinical Immunology under the mentorship of Professor George Tsokos, a leading expert in Systemic Lupus Erythematosus (SLE). His work has led to over 80 publications in high-impact journals such as the New England Journal of Medicine, Science Advance, Science Translational Medicine, Science Immunology, Lancet Rheumatology, Journal of Investigative Dermatology, British Journal of Dermatology, and JAMA Dermatology, and reviews in Nature Reviews Rheumatology and Trends Molecular Medicine. Dr. Kolios’s passion for Immuno-Dermatology is driven by his desire to bridge basic research in inflammatory skin diseases with developing targeted, personalized treatment approaches for patients, finally leading to approaches including cures.